Y46: Antiepileptics and antiparkinsonism drugs
Y46.4: Iminostilbenes
Iminostilbenes refer to a class of drugs used primarily in the treatment of mental health disorders such as bipolar disorder and schizophrenia. These medications work by interacting with specific receptors in the brain to help regulate various neurotransmitters, which can bring about improvements in mood and behavior. However, like all drugs, they carry the risk of side effects. When adverse reactions occur due to the use of iminostilbenes, it falls under the ICD-10 classification Y46.4. These adverse effects may range from mild, such as drowsiness or dry mouth, to more serious complications like skin rashes, irregular heart rhythms or significant changes in blood cells. The reactions can also cause psychological symptoms such as restlessness, confusion, or unusual thoughts and behaviors. It's important to monitor any changes closely while taking these medications.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.